Genmab Technical Analysis

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>GA</div>
GMAB -- Denmark Stock  

DKK 2,182  38.00  1.71%

As of the 4th of July, Genmab AS retains the downside deviation of 2.34, and risk adjusted performance of 0.683. Genmab AS technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Genmab AS, which can be compared to its competitors. Please check out Genmab AS standard deviation, information ratio, treynor ratio, as well as the relationship between the variance and jensen alpha to decide if Genmab AS is priced fairly, providing market reflects its last-minute price of 2182.0 per share.

Search Technical Analysis

 
Refresh
Genmab AS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Genmab AS technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Genmab AS trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Genmab AS Technical Analysis

Indicator
Time Period
  Portfolio Suggestion    
  
Execute Indicator
 
The output start index for this execution was twenty-five with a total number of output elements of thirty-six. The Normalized Average True Range is used to analyze tradable apportunities for Genmab AS across different markets. View also all equity analysis or get more info about normalized average true range volatility indicators indicator.

Genmab AS Trend Analysis

Use this graph to draw trend lines for Genmab AS. You can use it to identify possible trend reversals for Genmab AS as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Genmab AS price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Genmab AS Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Genmab AS applied against its price change over selected period. The best fit line has a slop of   13.81  , which means Genmab AS will continue producing value for investors. It has 122 observation points and a regression sum of squares at 7208817.81, which is the sum of squared deviations for the predicted Genmab AS price change compared to its average price change.

About Genmab AS Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Genmab AS on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Genmab AS based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Genmab AS stock first instead of the macroeconomic environment surrounding Genmab AS . By analyzing Genmab AS's financials, daily price indicators, and its related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Genmab AS's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Genmab AS specific price patterns or momentum indicators. Please read more on our technical analysis page.

Genmab AS July 4, 2020 Technical Indicators

Most technical analysis of Genmab stock help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Genmab from various momentum indicators to cycle indicators. When you analyze Genmab charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators
Risk Adjusted Performance0.683
Mean Deviation1.83
Semi Deviation1.68
Downside Deviation2.34
Coefficient Of Variation313.4
Standard Deviation2.37
Variance5.61
Information Ratio0.2045
Total Risk Alpha0.4561
Sortino Ratio0.2072
Maximum Drawdown11.48
Value At Risk(2.74)
Potential Upside4.49
Downside Variance5.47
Semi Variance2.84
Expected Short fall(2.08)
Skewness(0.21)
Kurtosis0.6286
Please check Risk vs Return Analysis. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page